Literature DB >> 12222877

Cell-mediated gene therapy for bone formation and regeneration.

Gadi Turgeman1, Hadi Aslan, Zulma Gazit, Dan Gazit.   

Abstract

Cell-mediated gene therapy is one of the new modalities branching out from the wide-ranging field of gene transfer and therapy. When applied to bone formation and regeneration, it has particular advantages depending on the type of cell used as a platform for gene delivery. When utilizing adult mesenchymal stem cells or osteoprogenitor cells for the expression of bone-promoting osteogenic factors, the cells not only express the factors promoting bone growth, but can respond, differentiate and participate in the bone formation process. The ability of engineered cells to respond to the transgene, as well as to other local signals in vivo, confers on them special properties that enable the formation and regeneration of large-scale bone tissue. This approach is a paradigm for the development of gene therapy strategies for other skeletal tissues. Here, we review the most recent studies related to cell-mediated gene therapy for bone formation and regeneration.

Mesh:

Year:  2002        PMID: 12222877

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  4 in total

Review 1.  Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.

Authors:  Diptiman Chanda; Sanjay Kumar; Selvarangan Ponnazhagan
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

Review 2.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

3.  Enhanced bone formation in large segmental radial defects by combining adipose-derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffold.

Authors:  Wei Hao; Jinlei Dong; Ming Jiang; Junwei Wu; Fuzhai Cui; Dongsheng Zhou
Journal:  Int Orthop       Date:  2010-02-07       Impact factor: 3.075

4.  Development of 3D in vitro platform technology to engineer mesenchymal stem cells.

Authors:  Hossein Hosseinkhani; Po-Da Hong; Dah-Shyong Yu; Yi-Ru Chen; Diana Ickowicz; Ira-Yudovin Farber; Abraham J Domb
Journal:  Int J Nanomedicine       Date:  2012-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.